🇺🇸 FDA
Pipeline program

ATRA+Venetoclax+Azacitidine

SOOCHOW-HY-2024-12-10

Unknown small_molecule active

Quick answer

ATRA+Venetoclax+Azacitidine for AML, Adult is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
AML, Adult
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials